New drug substantially extends survival in pancreatic cancer
A new form of chemotherapy that destroys new blood vessels that grow around tumors has produced excellent results in a phase II trial of patients with inoperable pancreatic cancer, researchers report at the 33rd Congress of the European Society for Medical Oncology (ESMO) in Stockholm. European investigators led by Prof. Matthias Löhr from the Karolinska Institute evaluated the efficacy and safety of three different doses of cationic lipid complexed paclitaxel (EndoTAG-1) administered twice weekly, in combination with weekly infusions of gemcitabine, compared to gemcitabine alone, in 200 patients with pancreatic adenocarcinoma.
"EndoTAG consists of charged particles that bind preferentially to the fast-growing endothelial cells in new blood vessels being formed by tumors," Prof. Löhr explained. "The drug, paclitaxel, is then released and thus directly reaches an important target in tumors, i.e. the vessels. Paclitaxel itself is not very efficient in pancreratic cancer."
After following patients for a year, the researchers found that treatment with such combination led to a substantially extended median survival time compared to standard therapy. Patients given gemcitabine alone survived on average 7.2 months, compared to up to 13.6 months for patients who received repeated doses of the combination (EndoTAG plus gemcitabine).
"These results are the best I have ever seen in palliative treatment in pancreatic cancer," Prof. Löhr said. "The results are really excellent and a phase III study is in the making."
Source: European Society for Medical Oncology
Articles on the same topic
- European disparities in access to cancer drugsTue, 16 Sep 2008, 14:44:19 UTC
- Study establishes role for gefitinib in Asian nonsmokers with lung cancerTue, 16 Sep 2008, 14:44:17 UTC
- Promising new treatment option for women with recurrent ovarian cancerMon, 15 Sep 2008, 15:17:00 UTC
- Investigational drug shows promise in ovarian cancerMon, 15 Sep 2008, 14:29:29 UTC
- Ovarian cancer drug trial reveals promising new treatmentMon, 15 Sep 2008, 14:29:17 UTC
Other sources
- New Drug Substantially Extends Survival In Pancreatic Cancerfrom Science DailyWed, 17 Sep 2008, 19:14:24 UTC
- Investigational drug shows promise in ovarian cancerfrom Biology News NetWed, 17 Sep 2008, 12:14:41 UTC
- New ovarian cancer treatment is developedfrom UPITue, 16 Sep 2008, 19:07:12 UTC
- New drug substantially extends survival in pancreatic cancerfrom PhysorgTue, 16 Sep 2008, 14:43:28 UTC
- Investigational drug shows promise in ovarian cancerfrom Biology News NetMon, 15 Sep 2008, 22:21:58 UTC
- Hope, confusion in hunt for ovarian cancer testsfrom PhysorgMon, 15 Sep 2008, 20:28:33 UTC
- Hope, confusion in hunt for ovarian cancer testsfrom AP HealthMon, 15 Sep 2008, 19:42:56 UTC
- Investigational drug shows promise in ovarian cancerfrom PhysorgMon, 15 Sep 2008, 15:14:57 UTC
- Ovarian Cancer Drug Trial Reveals Promising New Treatmentfrom Science DailyMon, 15 Sep 2008, 14:28:18 UTC
- Investigational Drug Shows Promise In Ovarian Cancerfrom Science DailyMon, 15 Sep 2008, 14:28:12 UTC